Contemporary issues for spontaneous abortion: Does recurrent abortion exist?

Obstetrics and Gynecology Clinics of North America

Volumn 27, Issue 3, 2000, Pages 541-554

  Reindollar, Richard H ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KARYOTYPE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION;

EID: 0033847720     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70154-6     Document Type: Article

References (38)

1. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous abortions
2. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
3. Future pregnancy outcome in unexplained recurrent first trimester miscarriage
4. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomized controlled trial
5. Intravenous immunoglobulin for treatment of recurrent pregnancy loss
6. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage
7. Prenatal genetic diagnosis following recurrent early pregnancy loss
8. Measurement of embryotoxic factors is predictive of pregnancy outcome in women with a history of recurrent abortion
9. Early embryonic mortality in women
10. Pregnancies in septate uteri: Outcome in relation to site of uterine implantation as determined by sonography
11. Intravenous immunoglobulin in the prevention of recurrent miscarriage
12. Intravenous immune globulin in recurrent abortion
13. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: A double-blind placebo-controlled study
14. Antiphospholipid antibody associated with recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
15. Study of abortion sequences
16. Fetal loss after implantation: A prospective study
17. Embryonic karyotypes of abortuses in relation to the number of previous miscarriages
18. Short-term therapy for recurrent abortion using intravenous immunoglobulins: Results of a double-blind placebo-controlled Italian study
19. Reproductive counseling in patients who have had a spontaneous abortion
20. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
21. Antiphospholipid antibodies, infertility and recurrent miscarriage
22. Hypersecretion of luteinising hormone, infertility and miscarriage
23. Maternal-fetal relation: Absence of an immunologic blocking factor from serum of women with chronic abortions
24. Reproductive history as a predictor of chromosomal abnormality in spontaneous losses
25. HLA-A, B compatibility in parents of offspring with neural tube defects or couples experiencing involuntary fetal wastage
26. Immunotherapy for recurrent miscarriage
27. Mullerian defects in women with normal reproductive outcome
28. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: A prospective, randomized, double-blind, placebo-controlled trial
29. Frequency of abnormal karyotypes among aborted fetuses from women with and without a history of recurrent spontaneous abortion
30. T-mycoplasma colonization in reproductive failure
31. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion
32. Etiologies and subsequent reproductive performance of 100 couples with recurrent abortion
33. On the possibility that a woman who has had a spontaneous abortion will abort in subsequent pregnancies
34. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions
35. Outcome of progesterone treatment of luteal phase inadequacy
36. X-linked dominant inherited diseases with lethality in hemizygous males
37. Incidence of early loss of pregnancy